跳至主要内容
临床试验/ISRCTN85736336
ISRCTN85736336已完成不适用

Controlled study of hepatitis B virus level alteration in hepatocellular carcinoma: monotherapy with transcatheter arterial chemoembolisation versus double therapy with transcatheter arterial chemoembolisation and interferon-alpha: a randomised controlled trial

Affiliated 10th People's Hospital of Tongji University (China)0 个研究点目标入组 116 人开始时间: 2009年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
116

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Image or pathologically diagnosed HCC
  • 2. Newly diagnosed HCC
  • 3. Unresectable HCC
  • 4. Positive serum HBS-Ag and HBe-Ag
  • 5. Child-Pugh scale A and B
  • 6. Older than 20 years, either sex
  • 7. Patients without jaundice

排除标准

  • 1. Previous history of antiviral therapy
  • 2. Baseline serum alanine aminotransferase (ALT) level 2.5 times the upper limit of normal or higher
  • 3. Serum HBV DNA level greater than 107 copies/mL
  • 4. Main portal vein thrombosis
  • 5. Underlying cardiac or renal diseases
  • 6. Positive tests for antibody to hepatitis C virus or human immunodeficiency virus
  • 7. Child?Pugh classification C
  • 8. Pre-existing evidence of hepatic decompensation

研究者

发起方
Affiliated 10th People's Hospital of Tongji University (China)

相似试验

Controlled study of hepatitis B virus level... | 临床试验